Tracking Cathie Wood: Betting on AI software stock PLTR, cashing out AMD and continuing to clean up SRTA

Last Friday (April 10), tensions in the Middle East escalated again, putting the ceasefire between the U.S. and Iran to the test. Despite macroeconomic uncertainties, U.S. chip stocks remained strong, with the Philadelphia Semiconductor Index rising over 2% to hit another all-time high, accumulating gains of over 13% last week.

Against this backdrop, Ark's moves were very concise and clear: shifting funds into AI software stocks $Palantir (PLTR.US)$ , while continuing to decisively 'clean house' on traditional medical device stocks.

Buying direction: heavy bets placed on Palantir, the AI data analysis giant.

Driven by both news and fundamentals, ARK’s buy-side inflows were highly concentrated that day.A single large purchase was made on the AI big data analytics giant, $Palantir (PLTR.US)$amounting to as many as 855,000 shares.

On the news front, former U.S. President Trump posted on his Truth Social platform on Friday praising artificial intelligence software firm Palantir, boosting the stock’s performance and driving it to rebound from intraday lows. More fundamentally, as tensions in the Middle East continue to escalate, reports suggest the U.S. military is using Palantir’s AI-driven Maven Intelligence Platform to identify targets in the region, tied to airstrikes against Iran that began at the end of February.

As a company with more than half of its U.S. revenue coming from government sectors (including the Pentagon and Immigration and Customs Enforcement), PLTR possesses unmatched capabilities in data integration and AI model building within the political and military fields. ARK chose this moment to aggressively accumulate shares, recognizing that under the current macro environment, the company can convert AI software into tangible government contracts, providing extremely high earnings certainty.

Sell-side direction: Taking profits at high levels on chip giant AMD, continuing to unload traditional healthcare company SRTA.

On the sell-side, ARK's 'out with the old, in with the new' and 'sector rotation' moves are working hand in hand.

First, Ms. Wood significantly reduced her position in AI chip giant Advanced Micro Devices. $Advanced Micro Devices (AMD.US)$A total of 44,400 shares.This does not mean ARK is bearish on the AI sector; rather, it reflects sector rotation and profit-taking. The semiconductor hardware and computing power sectors had substantial cumulative gains earlier, so ARK chose to cash out some hardware positions at this juncture to free up liquidity.

Secondly, Ms. Wood continued aggressively selling off Strata Critical Medical, a critical care medical equipment company. $Strata Critical Medical (SRTA.US)$As many as 75,400 shares.This follows the logic of portfolio adjustments from the past few days. Multiple days of large-scale sales at tens of thousands of shares reaffirm that these legacy healthcare assets are being removed from Ms. Wood's core investment portfolio.

Futubull[Opportunity Page]Celebrity portfolio tracking is now live! Choose from multiple celebrity portfolios, one-click follow the experts' strategies, precisely target high-quality stocks, and invest with more confidence!

365K Views